Aimin Li

Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma

Y. Luo, Y. Peng, Guojing Wu, 2022, Frontiers in Genetics.

AHSA1 Promotes Proliferation and EMT by Regulating ERK/CALD1 Axis in Hepatocellular Carcinoma

Jiakang Zhang, Y. Luo, D. Zheng, 2022, Cancers.

An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma

M. Caligiuri, B. Kaur, Mingye Feng, 2021, Nature Communications.

The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus

M. Caligiuri, Martha Milanes-Yearsley, B. Barker, 2021, Journal of virology.

Factor Xa cleaves SARS-CoV-2 spike protein to block viral entry and infection

M. Caligiuri, S. Whelan, B. Barker, 2023, Nature Communications.

The K18-hACE2 Transgenic Mouse Model Recapitulates Non-Severe and Severe COVID-19 in Response to Infectious Dose of SARS-CoV-2 Virus

M. Caligiuri, Martha Milanes-Yearsley, P. Keim, 2021, bioRxiv.

Targeting of Annexin A1 in Tumor-associated Macrophages as a Therapeutic Strategy for Hepatocellular Carcinoma.

Xiang Wang, Y. Luo, Zheng-Xiang Song, 2023, Biochemical pharmacology.

Wenqingyin suppresses ferroptosis in the pathogenesis of sepsis-induced liver injury by activating the Nrf2-mediated signaling pathway.

Bin Liu, Bo Deng, Yuting Wu, 2023, Phytomedicine : international journal of phytotherapy and phytopharmacology.